GERM vs. SYNB ETF Comparison
Comparison of ETFMG Treatments Testing and Advancements ETF (GERM) to Putnam BioRevolution ETF (SYNB)
GERM
ETFMG Treatments Testing and Advancements ETF
GERM Description
GERM is designed to give direct exposure to the biotech companies directly engaged in the testing and treatments of infectious diseases. Focused on advancements with targeted exposure to the forefront of R&D, vaccines, therapies and testing technologies.
Grade (RS Rating)
Last Trade
$19.16
Average Daily Volume
1,248
Number of Holdings
*
2
* may have additional holdings in another (foreign) market
SYNB
Putnam BioRevolution ETF
SYNB Description
Putnam BioRevolution ETF is an exchange traded fund launched and managed by Putnam Investment Management, LLC. The fund is co-managed by Putnam Investments Limited. It invests in the public equity markets. It invests in stocks of companies operating across healthcare, pharmaceuticals, biotechnology, life sciences and biology revolution sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. Putnam BioRevolution ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$32.51
Average Daily Volume
219
Number of Holdings
*
9
* may have additional holdings in another (foreign) market
Performance
Period | GERM | SYNB |
---|---|---|
30 Days | 3.00% | 1.41% |
60 Days | 3.68% | 6.01% |
90 Days | -2.06% | 4.28% |
12 Months | -0.17% | 23.42% |
0 Overlapping Holdings
Symbol | Grade | Weight in GERM | Weight in SYNB | Overlap |
---|
GERM: Top Represented Industries & Keywords
Industries:
Biotechnology
Drug Manufacturers - General
SYNB: Top Represented Industries & Keywords